|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.921
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.773
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.722
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.701
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.698
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.693
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.689
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.674
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.655
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.651
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.649
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.636
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.596
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.593
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.592
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.588
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.587
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.577
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.572
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.532
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.493
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.485
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.484
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.480
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.460
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.454
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.453
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.445
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.444
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.440
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.438
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.437
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.420
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.419
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.416
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.412
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.411
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.401
|
Mouse |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.398
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.377
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.365
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.365
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.361
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.353
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.351
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.351
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.347
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.344
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.342
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.342
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.329
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.325
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.313
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.312
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.307
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.303
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.300
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.296
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.294
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.294
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.291
|
Mouse |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.282
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.270
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.269
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.266
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.264
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.263
|
Worm |
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.258
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.255
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.251
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.251
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.250
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.240
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.239
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.238
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.235
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.234
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.234
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.232
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.231
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.230
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.230
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.229
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.228
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.227
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.227
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.226
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.225
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.221
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.220
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.217
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.215
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.214
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.212
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.210
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.209
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.208
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.205
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.204
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.204
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.200
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.199
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.197
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.195
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.192
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.188
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.181
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.180
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.179
|
Mouse |
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.178
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.176
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.176
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.176
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.174
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.172
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.170
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.170
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.170
|
|
|
|
activation of janus kinase activity
|
GO:0042976 |
2 |
0.168
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.165
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.163
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.163
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.162
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.162
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.162
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.161
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.160
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.160
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.160
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.156
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.156
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.155
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.154
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.153
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.152
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.150
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.149
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.148
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.148
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.148
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.148
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.146
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.146
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.145
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.145
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.144
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.144
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.144
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.142
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.142
|
|
|
|
axon regeneration
|
GO:0031103 |
12 |
0.142
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.141
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.139
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.138
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.136
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.136
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.135
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.134
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.133
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.132
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.131
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.130
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.130
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.130
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.128
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.127
|
|
|
|
regulation of neurotrophin trk receptor signaling pathway
|
GO:0051386 |
4 |
0.126
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.124
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.124
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.121
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.121
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.120
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.117
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.117
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.117
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
27 |
0.116
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.116
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.116
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.115
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.114
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.113
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.113
|
Mouse |
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.112
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.111
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.111
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.109
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.109
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.108
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.108
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.106
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.105
|
|
|
|
positive regulation of sphingolipid biosynthetic process
|
GO:0090154 |
1 |
0.104
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.104
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.102
|
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.100
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.100
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.100
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.099
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.099
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.098
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.097
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.097
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.097
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.097
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.096
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.096
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.096
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.096
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.095
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.095
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.093
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.093
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.092
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.091
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.091
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.091
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.090
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.090
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.090
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.089
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.089
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.089
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.088
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.088
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.088
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.088
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.087
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.087
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.087
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.086
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.086
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.086
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.086
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.085
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.085
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.085
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.084
|
|
|
|
negative regulation of neurotrophin trk receptor signaling pathway
|
GO:0051387 |
2 |
0.084
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.083
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.083
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.083
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.082
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.082
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.081
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.081
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.081
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.081
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.081
|
|
|
|
regulation of transcription factor import into nucleus
|
GO:0042990 |
24 |
0.081
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.081
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.080
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.080
|
|
|
|
regulation of activation of jak2 kinase activity
|
GO:0010534 |
1 |
0.080
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.080
|
Mouse |
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.080
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.080
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.080
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.079
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.079
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.079
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.078
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.078
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.077
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.077
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.077
|
Mouse |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.077
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.077
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.076
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.076
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.074
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.074
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.074
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.074
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.073
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.073
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.073
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.072
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.072
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.071
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.071
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.070
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.070
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.069
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.069
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.069
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.067
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.067
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.067
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.066
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.066
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.065
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.065
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.065
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.065
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.064
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.064
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.063
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.063
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.062
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.062
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.061
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.061
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.061
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.061
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.061
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.061
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.061
|
|
|
|
vitellogenesis
|
GO:0007296 |
2 |
0.060
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
19 |
0.059
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.059
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.059
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.059
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.059
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.058
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.058
|
|
|
|
positive regulation of lipase activity
|
GO:0060193 |
6 |
0.058
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.058
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.058
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.058
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.058
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.057
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.057
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.057
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.056
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.056
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.056
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.056
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.056
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.056
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.056
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.056
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.055
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.055
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.055
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.054
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
14 |
0.054
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.054
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.054
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.054
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.053
|
|
|
|
innervation
|
GO:0060384 |
22 |
0.053
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.053
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.052
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.052
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.052
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.052
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.052
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.051
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.051
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.051
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.050
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.050
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.050
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.050
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.050
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.050
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.050
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.049
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.049
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.049
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.049
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.049
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.049
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.049
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.048
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.048
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.048
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.048
|
|
|
|
epiboly
|
GO:0090504 |
8 |
0.048
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.048
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.048
|
|
|
|
negative regulation of t helper 2 cell differentiation
|
GO:0045629 |
4 |
0.047
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.047
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.047
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.047
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.047
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.047
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.047
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.047
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.047
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.047
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.047
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.046
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.046
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.046
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.046
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.046
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.045
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.045
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.045
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.044
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.044
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.044
|
|
|
|
apoptotic cell clearance
|
GO:0043277 |
17 |
0.044
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.044
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.044
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.044
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.044
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.043
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.043
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.043
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.043
|
|
|
|
notochord development
|
GO:0030903 |
20 |
0.043
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.043
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.043
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.043
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.043
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.042
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.042
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.042
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.042
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.041
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.041
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.041
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.041
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
2 |
0.041
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.041
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.041
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.041
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.041
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.041
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.040
|
|
|
|
wound healing spreading of cells
|
GO:0044319 |
8 |
0.040
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.040
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.040
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.040
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.040
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.039
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.039
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.039
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.039
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.039
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.039
|
|
|
|
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator
|
GO:1902238 |
1 |
0.038
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.038
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.038
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.038
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.038
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.038
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.038
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.038
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.038
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.038
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.038
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.038
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.037
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.037
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.037
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.037
|
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.037
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.037
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.037
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.036
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.036
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.036
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.036
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.035
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.035
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
12 |
0.035
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.035
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.035
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.035
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.035
|
Mouse |
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.035
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.035
|
|
|
|
positive regulation of cartilage development
|
GO:0061036 |
18 |
0.035
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.035
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.035
|
|
|
|
regulation of activation of janus kinase activity
|
GO:0010533 |
1 |
0.035
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.035
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.035
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.034
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.034
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.034
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.034
|
|
|
|
chondrocyte proliferation
|
GO:0035988 |
6 |
0.034
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.034
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.034
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.034
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.034
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.034
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.034
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.034
|
|